Arrowhead Pharmaceuticals (ARWR) Cash & Equivalents (2010 - 2026)
Arrowhead Pharmaceuticals (ARWR) reported Cash & Equivalents of $54.8 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 57.8% from $129.79 million a year earlier and down 70.9% from the prior quarter.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Arrowhead Pharmaceuticals posted Cash & Equivalents of $226.55 million, up 120.6% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of 9.5% (FY2020 to FY2025).
- By fiscal year, Cash & Equivalents came in at $102.69 million in FY2024 (-7.4%), $110.89 million in FY2023 (+2.7%), $108.01 million in FY2022 (-41.4%) and $184.43 million in FY2021 (+28.5%).
- The fiscal Q3 2026 figure ranks as the lowest quarterly Cash & Equivalents since fiscal Q1 2025.
- Year over year, Cash & Equivalents gained in five of the last eight quarters, with growth averaging 57.0%.
- The high point for year-over-year Cash & Equivalents in five years was fiscal Q1 2026 (growth of 274.2%); the low point was fiscal Q2 2022 (a decline of 76.8%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $188.52 million (Q2 2026), $201.64 million (Q1 2026) and $226.55 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Arrowhead Pharmaceuticals | 9.06 Bn | 3.84 Bn | - | 54.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54.80 Mn |
| Mar 31, 2026 | 188.52 Mn |
| Dec 31, 2025 | 201.64 Mn |
| Sep 30, 2025 | 226.55 Mn |
| Jun 30, 2025 | 129.79 Mn |
| Mar 31, 2025 | 185.71 Mn |
| Dec 31, 2024 | 53.89 Mn |
| Sep 30, 2024 | 102.69 Mn |
| Jun 30, 2024 | 69.40 Mn |
| Mar 31, 2024 | 127.70 Mn |
| Dec 31, 2023 | 58.22 Mn |
| Sep 30, 2023 | 110.89 Mn |
| Jun 30, 2023 | 105.33 Mn |
| Mar 31, 2023 | 134.96 Mn |
| Dec 31, 2022 | 202.25 Mn |
| Sep 30, 2022 | 108.01 Mn |
| Jun 30, 2022 | 139.44 Mn |
| Mar 31, 2022 | 86.41 Mn |
| Dec 31, 2021 | 91.60 Mn |
| Sep 30, 2021 | 184.43 Mn |
API Access
Arrowhead Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();